caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1427001296

David NeubauerM.D.

PRACTICEJOHNS HOPKINS BAYVIEWSee all providers at this practice →
Pulmonary DiseaseBaltimore, MDI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where David Neubauer's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 6 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Anita Everett
Psychiatry & Neurology · Baltimore, MD
1473
Philip Smith
Pulmonary Disease · Baltimore, MD
1337
Quest Diagnostics Incorporated Md
Clinical Laboratory · Baltimore, MD
1137
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
JOHNS HOPKINS BAYVIEW MEDICAL CENTER INC88347
THE JOHNS HOPKINS HOSPITAL2365
Anita Everett
Psychiatry & Neurology · Baltimore, MD
22106
Quest Diagnostics Incorporated Md
Clinical Laboratory · Baltimore, MD
1225
Alan Schwartz
Pulmonary Disease · Baltimore, MD
1235
Philip Smith
Pulmonary Disease · Baltimore, MD
1143
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
98
Unique beneficiaries
—
Total services
132
Distinct HCPCS
2
Medicare payment
$7K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 197 Pulmonary Disease providers in MD — bottom quintile (cohort median 796).
QUALITY · MIPS · 2024
Final MIPS score
83.3
Quality
73.9
Cost
70.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.35%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
3,507
Beneficiaries
—
Total drug cost
$262K
Distinct drugs
49
Brand share
14.2%
Top prescribed drugs
Benztropine Mesylate366 claims
Olanzapine267 claims
Quetiapine Fumarate229 claims
Haloperidol Decanoate192 claims
Clonazepam154 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$19K
Payment records
15
By payment type
Consulting Fee$13K
Travel and Lodging$5K
Food and Beverage$460